Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

In 2007, we conducted a prospective randomized study to compare an aggressive dose escalation (group B, n = 123) with the standard dose escalation proposed by European LeukemiaNet (group A, n = 122). In group B, if patients did not achieve a complete cytogenetic response (CCyR) at 3 months or did no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Miyamura, Koichi, Ohnishi, Kazunori, Ohtake, Shigeki, Usui, Noriko, Nakaseko, Chiaki, Fujita, Hiroyuki, Fujisawa, Shin, Sakura, Toru, Okumura, Hirokazu, Iriyama, Noriyoshi, Emi, Nobuhiko, Fujimaki, Katsumichi, Honda, Sumihisa, Miyazaki, Yasushi, Naoe, Tomoki
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373759/
https://ncbi.nlm.nih.gov/pubmed/30705033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018025981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados